About SAMDI Tech
SAMDI Tech is a Healthcare company based in Chicago (United States) founded in 2011, and was acquired by Charles River Laboratories in January 2023. High-throughput MALDI-TOF platform is utilized for screening services. The company has 8 employees. SAMDI Tech offers products and services including SAMDI Mass Spectrometry and Screening Libraries. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Proteomics. Its legal entity is SAMDI TECH, INC. Its competitors include Nautilus Biotechnology, ProteinSimple and Somalogic; 3 of its 3 listed competitors have raised funding.
Company details
SAMDI Tech is a biotech company developing a platform for high-throughput screening that combines MALDI-TOF mass spectrometry with high-density arrays for rapid, quantitative measurements of analytes in biochemical reactions. The arrays are manufactured in 384 or 1536 formats and are compatible with standard laboratory automation systems. Each spot on the array uses a thin layer of gold with a self-assembled monolayer for controlled analyte capture. The company offers assay development services (assay transfer to the SAMDI format, Km determination, Enz vs Velocity, IC50 determination, DMSO tolerance, etc), and a range of standardized in vitro assays (methyltransferases, demethylases, acetyltransferases, kinases, phosphatases, deiminases, ubiquitin ligases, deubiquitinases, proteases, ligases, glycosyltransferases, glycosidases, acyltransferases, polymerases, etc). SAMDI Tech also has a library of 350,000 small molecule compounds that it offers for HTS screens.
- Headquarters Chicago, United States
- Employees 8
- Stage Acquired
- SectorsHealthcare
- Website samditech.com
- Social LinkedIn X Facebook
- Acquired by Charles River Laboratories (Jan 2023)
- Legal Name Samdi Tech, Inc.
- Latest Funding Round$2M (USD), Grant
Jul 2020
- InvestorsCharles River Laboratories
& 2 more
- Employee Count8
- Acquired byCharles River Laboratories
(Jan 2023)
Products & Services of SAMDI Tech
SAMDI Tech offers a comprehensive portfolio of products and services, including SAMDI Mass Spectrometry and Screening Libraries.
Facilitates label-free drug screening and enzyme activity analysis.
Offers curated compound collections for drug discovery research.
Funding Insights of SAMDI Tech
- Total Rounds 4
- Last Round Grant — $2M
- First Round $180,000
(Jun 2011)
- Investors Count 2
All 4 funding rounds of SAMDI Tech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | $2M | Grant | – | – | |
| Aug 2019 | $224,978 | Grant | – | – | |
| Jul 2011 | $180,000 | Grant | – | – | |
| Jun 2011 | $180,000 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in SAMDI Tech
SAMDI Tech has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Charles River Laboratories, HHS and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Provider of drug discovery and preclinical development services | 1947 | criver.com | Wilmington, United States |
Investor details for SAMDI Tech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of SAMDI Tech
4 dated milestones of SAMDI Tech across 12 years, from founding to its latest funding, stage changes and deals.
- Founded SAMDI Tech is founded.
- Funding First funding round of $180K.
- Funding Latest funding round, Grant, of $2.0M.
- Exit Acquired by Charles River Laboratories.
Competitors of SAMDI Tech
SAMDI Tech has 3 listed competitors in our database, 3 of them funded. They include Nautilus Biotechnology, ProteinSimple and Somalogic.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nautilus.bio | 2016 | Seattle, United States | $103.26M | 134 | A proteomics platform is developed for analyzing the human proteome. | |
| proteinsimple.com | 2004 | San Jose, United States | $114.29M | 157 | Provider tools to help researchers with protein analysis | |
| somalogic.com | 1999 | Boulder, United States | $663.99M | 319 | Protein-based assays are developed for life science research. |
Detailed competitors of SAMDI Tech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as SAMDI Tech (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Samdi Tech
Complete news archive for SAMDI Tech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SAMDI Tech
SAMDI Tech was founded in 2011.
SAMDI Tech is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
SAMDI Tech has 8 employees.
SAMDI Tech is a biotech company developing a platform for high-throughput screening that combines MALDI-TOF mass spectrometry with high-density arrays for rapid, quantitative measurements of analytes in biochemical reactions. The arrays are manufactured in 384 or 1536 formats and are compatible with standard laboratory automation systems. Each spot on the array uses a thin layer of gold with a self-assembled monolayer for controlled analyte capture. The company offers assay development services (assay transfer to the SAMDI format, Km determination, Enz vs Velocity, IC50 determination, DMSO tolerance, etc), and a range of standardized in vitro assays (methyltransferases, demethylases, acetyltransferases, kinases, phosphatases, deiminases, ubiquitin ligases, deubiquitinases, proteases, ligases, glycosyltransferases, glycosidases, acyltransferases, polymerases, etc). SAMDI Tech also has a library of 350,000 small molecule compounds that it offers for HTS screens.
SAMDI Tech's top competitors include Somalogic, Nautilus Biotechnology and ProteinSimple.
SAMDI Tech offers SAMDI Mass Spectrometry and Screening Libraries.
SAMDI Tech has 3 investors. Key investors include Charles River Laboratories, HHS, and National Science Foundation.
SAMDI Tech operates through Samdi Tech, Inc..
Yes. SAMDI Tech was acquired by Charles River Laboratories in January 2023.